Entheon Biomedical CEO Timothy Ko and John Lem, the founder of Lobo Genetics are singular in their mission to research genetic driven approaches to developing personalized tools for use in psychedelic-assisted therapeutic treatments for substance use disorders.
With firsthand knowledge of the shortcomings of the current treatment system, Ko, and Lem, the developer behind a direct-to-consumer platform being used in HaluGen’s Psychedelic Genetics test kit, the two are working together to find the right solutions for patients faster and improve outcomes.
Entrepreneurs are the backbone of Canada’s economy. To support Canada’s businesses, subscribe to our YouTube channel and follow us on Facebook, Instagram, LinkedIn and Twitter.
Want to stay up-to-date on the latest #entrepreneur podcasts and news? Subscribe to our bi-weekly newsletter
